These investigators also showed that treatment of prostate cancer cells with ET-1 caused a downregulation of some of the apoptotic proteins such as Bad, Bax and Bak, suggesting the correlation of increased expression of ET-1 and cell survival in cancer cells [52]. The gene discussed is EDN1; the disease is prostate carcinoma.